Global News | World latest News| Trending News
Newswise — MIAMI, FLORIDA (STRICTLY EMBARGOED UNTIL MARCH 20, 2025, AT 11 A.M. EDT) – Since 2021, when lung cancer screening guidelines began to include younger people and those with a lower smoking history, the number of screenings climbed, but significant gaps remain, especially among people with limited access to healthcare, according to a new…
Newswise — MIAMI, FLORIDA (EMBARGOED UNTIL MARCH 17, 2025, AT NOON EDT) – Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy. But new research from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, suggests a way forward: suppressing a protein…
Miami, Florida – Feb. 4, 2025 – Firefighters are more likely to die of cancer than accidents or flames, but for the past 10 years, the nationally recognized Sylvester Firefighter Cancer Initiative (FCI) at Sylvester Comprehensive Cancer Center, part of UHealth – the University of Miami Health System, has been working to cut that risk. “Firefighters risk their…
Newswise — MIAMI, FLORIDA (Jan. 15, 2025) – The U.S. Surgeon General has recommended that alcoholic beverages carry cancer risk warning labels, citing a growing body of research that shows alcohol as a group 1 carcinogen. But more than half of U.S. residents don’t know that alcohol consumption increases their risk of developing cancer, or…
Newswise — MIAMI, FLORIDA (DEC. 11, 2024) – Stephen D. Nimer, M.D., has been awarded the American Society of Hematology’s (ASH) Mentor Award for 2024. He is one of two individuals receiving the award this year from the society which has more than 18,000 members. As director of Sylvester Comprehensive Cancer Center at the University of Miami…
Newswise — MIAMI, FLORIDA (STRICTLY EMBARGOED UNTIL DEC. 8, 2024, AT 12 NOON EST) – Two clinical trials testing the antibody loncastuximab tesirine (Zynlonta) showed encouraging results in patients with high-risk forms of two blood cancers – follicular lymphoma and marginal zone lymphoma. The findings, led by physician-scientists at Sylvester Comprehensive Cancer Center, part of…
MIAMI, FLORIDA (Dec. 10, 2024) – A new review published in Blood Cancer Discovery outlines a major multiple myeloma research project that supported a key regulatory decision by a U.S. Food and Drug Administration committee. The decision greenlights a new biomarker endpoint, minimal residual disease, for accelerated drug approval in multiple myeloma, and researchers say…
November Tip Sheet CANCER RESEARCH Sylvester Researchers to Share Insights at ASH 2024 Annual Meeting Dozens of physician-scientists and other investigators from Sylvester Cancer will share their insights at ASH 2024, the American Society of Hematology’s 66th-annual meeting in San Diego, Dec. 7-10. Sylvester researchers will be involved in more than 130 presentations, including oral,…
